{"topic_id":"cn_moa_pet_veterinary_drugs_timeline_2026","category":"cn-2026-approvals","context":"---\ntopic_id: cn_moa_pet_veterinary_drugs_timeline_2026\ncategory: cn-2026-approvals\ntitle: \"中国宠物用新兽药获批时间线 (China Pet Veterinary Drug Approval Timeline) — MOA Announcements No. 1022 through 1040, January–July 2026\"\nlang: en\nsource: ivdc-announcement-1038-20260707.html, ivdc-202605-t20260518_62268.html, ivdc-202606-t20260605_63436.html, ivdc-announcement-1040-20260713.html\ndate_parsed: 2026-07-21\ntokens_estimated: 800\nverification:\n  method: substring_match\n  claims: 6\n  passed: 6\n  date: 2026-07-21\nsource_document: \"China MOA Announcement / 农业农村部公告 (2026 approvals)\"\ncitation:\n  authority: \"China MOA — Announcement & Gazette series\"\n  title: \"中国宠物用新兽药获批时间线 (China Pet Veterinary Drug Approval Timeline) — MOA Announcements No. 1022 through 1040, January–July 2026\"\n  url: \"\"\n  retrieved: \"2026-07-21\"\n  ref: \"\"\n  doc_type: \"official web page\"\n  needs_review: true\nauthority_tier: T1\nauthority_tier_basis: \"T1:cn-gov\"\nauthority_tier_date: 2026-08-04\n---\n\n# China Pet Veterinary Drug Approval Timeline — MOA Announcements No. 1022 through 1040 (Jan–Jul 2026)\n\nThis topic provides a consolidated timeline of **pet-specific or pet-relevant new veterinary drug approvals** (新兽药) published by China's Ministry of Agriculture and Rural Affairs (农业农村部, MOA) across consecutive announcements from **Announcement No. 1022 through No. 1040**, spanning **January to July 2026**.\n\nAll new veterinary drug registrations listed below were approved under the *Regulations on the Administration of Veterinary Drugs* (《兽药管理条例》) and the *Measures for the Registration of Veterinary Drugs* (《兽药注册办法》), effective from their respective promulgation dates.\n\n## Timeline of Pet-Specific New Drugs (2026)\n\n### Announcement No. 1022 — 2026年5月14日 (May 14, 2026)\n\n**New veterinary drug registration certificate range (新兽药注册证书号范围):** （2026）新兽药证字 **50–55号**\n\n| Cert No. | Drug name | Class | Monitoring period | Note |\n|---|---|---|---|---|\n| 50 | Fluolaner (氟雷拉纳) | Category 2 (二类) | 4 years (4年) | Ectoparasiticide active ingredient (抗寄生虫活性成分) |\n| 51 | Fluolaner Drops (氟雷拉纳滴剂) | Category 2 (二类) | 4 years (4年) | Pet topical ectoparasiticide drops (宠物用外用抗寄生虫滴剂) |\n| 52 | Dangshen Shengmai Mixture (党参生脉合剂) | Category 3 (三类) | 3 years (3年) | Contains pet-pharma research units (含 pet pharma 研制单位) |\n| 53 | Fowl Adenovirus Egg-Yolk Antibody (禽腺病毒卵黄抗体) | Category 3 (三类) | 3 years (3年) | — |\n| 54 | Fusidic Acid Ophthalmic Solution (夫西地酸滴眼液) | Category 5 (五类) | 3 years (3年) | Pet ophthalmic drug (宠物用眼药) |\n| 55 | Pregabalin Oral Solution (普瑞巴林内服溶液) | Category 5 (五类) | 3 years (3年) | Pet analgesic, subject to prescription management (宠物用镇痛，纳入兽用处方药) |\n\n**Source:** MOA Announcement No. 1022 (农业农村部公告第1022号), 2026年5月14日 — `ivdc-202605-t20260518_62268.html`\n\n---\n\n### Announcement No. 1026 — 2026年6月4日 (June 4, 2026)\n\n**New veterinary drug registration certificate range (新兽药注册证书号范围):** （2026）新兽药证字 **56–65号**\n\n| Cert No. | Drug name | Class | Monitoring period | Note |\n|---|---|---|---|---|\n| 56 | Gralen (格拉匹仑) | Category 2 (二类) | 4 years (4年) | Active ingredient (活性成分) |\n| 57 | Gralen Tablets (格拉匹仑片) | Category 2 (二类) | 4 years (4年) | Canine osteoarthritis analgesia, pet-use (犬用骨关节炎镇痛，宠物用) |\n| 58 | Fowl Adenovirus Egg-Yolk Antibody (禽腺病毒卵黄抗体) | Category 3 (三类) | 3 years (3年) | — |\n| 59 | Canine Distemper Virus Antiserum (犬瘟热病毒抗血清) | Category 3 (三类) | 3 years (3年) | **Pet-use (宠物用)** |\n| 60 | Newcastle Disease, Egg-Drop Syndrome Combined Inactivated Vaccine (鸡新城疫、减蛋综合征三联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |\n| 61 | Pseudorabies Live Vaccine (猪伪狂犬病活疫苗) | Category 3 (三类) | 3 years (3年) | — |\n| 62 | Mink Distemper Live Vaccine (HL001-M3 Strain) (水貂犬瘟热活疫苗（HL001-M3株）) | Category 3 (三类) | 3 years (3年) | Pet/specialty-animal use (宠物/特种养殖用) |\n| 63 | Porcine Circovirus + Mycoplasma Hyopneumoniae Combined Inactivated Vaccine (猪圆环+肺炎支原体二联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |\n| 64 | Chicken Bursin Injection (鸡法氏囊素注射液) | Category 3 (三类) | 3 years (3年) | — |\n| 65 | Itraconazole Ointment (伊曲康唑软膏) | Category 4 (四类) | 3 years (3年) | Pet antifungal (宠物用抗真菌) |\n\n**Source:** MOA Announcement No. 1026 (农业农村部公告第1026号), 2026年6月4日 — `ivdc-202606-t20260605_63436.html`\n\n---\n\n### Announcement No. 1038 — 2026年7月6日 (July 6, 2026)\n\n**New veterinary drug registration certificate range (新兽药注册证书号范围):** （2026）新兽药证字 **66–71号**\n\n| Cert No. | Drug name | Class | Monitoring period | Note |\n|---|---|---|---|---|\n| 66 | Chlorhexidine Acetate Solution (醋酸氯己定溶液) | Category 3 (三类) | 3 years (3年) | Pet topical drug, for dog skin/wound/mucous-membrane disinfection (宠物用外用药，用于犬皮肤/创面/黏膜消毒) |\n| 67 | Huangsang Qingfei San (黄桑清肺散) | Category 3 (三类) | 3 years (3年) | — |\n| 68 | Porcine Circovirus Type 2 Baculovirus-Vector Inactivated Vaccine (SL08 Strain) (猪圆环病毒2型杆状病毒载体灭活疫苗（SL08株）) | Category 3 (三类) | 3 years (3年) | — |\n| 69 | Poultry Quadrivalent Inactivated Vaccine (鸡四联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |\n| 70 | Feline Rhinotracheitis + Calicivirus + Panleukopenia Combined Inactivated Vaccine (WX+SH14+0918 Strains) (猫鼻气管炎+猫杯状病毒+猫泛白细胞减少症三联灭活疫苗（WX株+SH14株+0918株）) | Category 3 (三类) | 3 years (3年) | **Pet cat vaccine (宠物用猫疫苗)** |\n| 71 | Gabapentin Oral Solution (加巴喷丁内服溶液) | Category 4 (四类) | 3 years (3年) | Pet analgesic, subject to prescription management (宠物用镇痛，纳入兽用处方药) |\n\n**Source:** MOA Announcement No. 1038 (农业农村部公告第1038号), 2026年7月6日 — `ivdc-announcement-1038-20260707.html`\n\n---\n\n## Cross-Cutting Observations\n\n1. **Pet new-veterinary-drug certificate numbers now cover 50–71号** (2026 annual series), representing a significant expansion of the domestic pet pharmaceutical catalogue.\n2. **Cat vaccine (猫用疫苗):** Announcement 1038 introduces the first **feline triple inactivated vaccine (猫三联灭活疫苗)** covering FVR, FCV and FPL in a single injection (certificate 证字70号), a notable milestone for domestic cat health products.\n3. **Companion-animal analgesics/neuro drugs (宠物用镇痛/神经用药):** Gabapentin (加巴喷丁, 证字71号) and Pregabalin (普瑞巴林, 证字55号) represent the first formally registered companion-animal neurology/pain-management drugs in China.\n4. **Ectoparasiticide (抗寄生虫):** Fluolaner (氟雷拉纳, 证字50–51号) is an isoxazoline-class compound registered as a novel pet ectoparasiticide.\n5. **Osteoarthritis (骨关节炎):** Gralen Tablets (格拉匹仑片, 证字57号) is the first registered canine osteoarthritis pain-management drug in China.\n\n---\n\n**Source:** Compiled from `ivdc-202605-t20260518_62268.html` · `ivdc-202606-t20260605_63436.html` · `ivdc-announcement-1038-20260707.html` · `ivdc-announcement-1040-20260713.html`\n","sources":["China MOA — Announcement & Gazette series — 中国宠物用新兽药获批时间线 (China Pet Veterinary Drug Approval Timeline) — MOA Announcements No. 1022 through 1040, January–July 2026 (retrieved 2026-07-21)"],"source":{"authority":"China MOA — Announcement & Gazette series","title":"中国宠物用新兽药获批时间线 (China Pet Veterinary Drug Approval Timeline) — MOA Announcements No. 1022 through 1040, January–July 2026","url":"http://www.moa.gov.cn/","retrieved":"2026-07-21","ref":"","doc_type":"official web page","source_document":"China MOA Announcement / 农业农村部公告 (2026 approvals)","verification_file":"ivdc-announcement-1038-20260707.html, ivdc-202605-t20260518_62268.html, ivdc-202606-t20260605_63436.html, ivdc-announcement-1040-20260713.html"},"source_document":"China MOA Announcement / 农业农村部公告 (2026 approvals)","source_file":"ivdc-announcement-1038-20260707.html, ivdc-202605-t20260518_62268.html, ivdc-202606-t20260605_63436.html, ivdc-announcement-1040-20260713.html","trust":{"authority_tier":"T1","fidelity":"verbatim","license":null,"display_grade":"A"},"tokens_estimated":800,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}